Source:http://linkedlifedata.com/resource/pubmed/id/20113320
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0021713,
umls-concept:C0031268,
umls-concept:C0032743,
umls-concept:C0040405,
umls-concept:C0205163,
umls-concept:C0301630,
umls-concept:C0332161,
umls-concept:C0546837,
umls-concept:C0599880,
umls-concept:C0851346,
umls-concept:C1517526,
umls-concept:C1521840,
umls-concept:C1522619,
umls-concept:C1704788,
umls-concept:C2349206
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-8-23
|
pubmed:abstractText |
Target volume definition in modern radiotherapy is based on planning computed tomography (CT). So far, 18-fluorodeoxyglucose positron emission tomography (FDG-PET) has not been included in planning modality in volume definition of esophageal cancer. This study evaluates fusion of FDG-PET and CT in patients with esophageal cancer in terms of geographic misses and inter-observer variability in volume definition. In 28 esophageal cancer patients, gross, clinical and planning tumor volumes (GTV; CTV; PTV) were defined on planning CT by three radiation oncologists. After software-based emission tomography and computed tomography (PET/CT) fusion, tumor delineations were redefined by the same radiation-oncologists. Concordance indexes (CCI's) for CT and PET/CT based GTV, CTV and PTV were calculated for each pair of observers. Incorporation of PET/CT modified tumor delineation in 17/28 subjects (61%) in cranial and/or caudal direction. Mean concordance indexes for CT-based CTV and PTV were 72 (55-86)% and 77 (61-88)%, respectively, vs. 72 (47-99)% and 76 (54-87)% for PET/CT-based CTV and PTV. Paired analyses showed no significant difference in CCI between CT and PET/CT. Combining FDG-PET and CT may improve target volume definition with less geographic misses, but without significant effects on inter-observer variability in esophageal cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1442-2050
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
493-501
|
pubmed:meshHeading |
pubmed-meshheading:20113320-Aged,
pubmed-meshheading:20113320-Aged, 80 and over,
pubmed-meshheading:20113320-Esophageal Neoplasms,
pubmed-meshheading:20113320-Female,
pubmed-meshheading:20113320-Fluorodeoxyglucose F18,
pubmed-meshheading:20113320-Humans,
pubmed-meshheading:20113320-Male,
pubmed-meshheading:20113320-Middle Aged,
pubmed-meshheading:20113320-Observer Variation,
pubmed-meshheading:20113320-Positron-Emission Tomography,
pubmed-meshheading:20113320-Radiographic Image Interpretation, Computer-Assisted,
pubmed-meshheading:20113320-Radiopharmaceuticals,
pubmed-meshheading:20113320-Radiotherapy, Conformal,
pubmed-meshheading:20113320-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:20113320-Retrospective Studies,
pubmed-meshheading:20113320-Tomography, X-Ray Computed
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
|
pubmed:affiliation |
Department of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|